Chemed Corp.
CHE
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
34.4% upsideUndervalued by 34.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.49 Billion |
|---|---|
| Enterprise Value | $6.71 Billion |
| Dividend Yield | $2.40 (0.49%) |
| Earnings per Share | $18.42 |
| Beta | 0.52 |
| Outstanding Shares | 13,675,000 |
Return
| Return on Equity | 30.64% |
|---|---|
| Return on Assets | 16.91% |
| Return on Invested Capital | 28.40% |
Valuation & Multiples
| P/E Ratio | 26.57 |
|---|---|
| PEG | -349.49 |
| Price to Sales | 2.64 |
| Price to Book Ratio | 7.88 |
| Enterprise Value to Revenue | 2.64 |
| Enterprise Value to EBIT | 19.47 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 92.41% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.12%▼ 91.34% |
|---|---|
| Total Invested | $7.34M▼ 99.85% |
| Investors Holding | 18▼ 478.00% |
ESG Score
No data
About Chemed Corp.
CEO: Kevin McNamara Relevant Senate Committees
The primary committee for taxation, trade, and entitlement spending, it directly legislates Medicare/Medicaid policy, reimbursement rates, and tax laws, all of which critically impact Chemed's revenue and profitability.
Directly controls and allocates federal spending for all government programs, including Medicare and Medicaid, which are the primary revenue sources for Chemed's home health and hospice services.
Directly regulates health policy and labor laws, impacting staffing costs, workforce regulations, and broader healthcare service delivery, all critical factors for Chemed.